Pimagedine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePimagedine
Drug Alias Name匹马吉定pimagedina氨基胍碳酸盐pimagedinumAminoguanidine hydrochloride +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase, inducible inhibitorsAdvanced glycation end product inhibitors
TargetsNitric oxide synthase, inducibleAdvanced glycation end product
Therapy Area/IndicationsDiabetic NephropathiesDiabetic RetinopathyEndotoxemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma IncSynvista
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRadboud University Medical CenterSynvistaUniversity Of Minnesota +[4] 
Active IndicationsN/A
Inactive IndicationsDiabetic NephropathiesDiabetic RetinopathyEndotoxemia

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG